February 2, 2024 – Woburn, MA
Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings, today announced that the company will be participating in the 2024 International Master Course on Aging Science (IMCAS) World Congress, taking place February 1 – 3, 2024, in Paris. Chief Executive Officer and President, Jon Edelson, MD, will present “Update on Eirion’s Topical and Liquid Injectable Botulinum” during the conference session “Updated and Future Aesthetic Toxins” that will take place on Saturday, February 3, 2:00 PM – 3:30PM CET.
“IMCAS is one of the premiere aesthetic conferences in the world, and I am excited to showcase Eirion’s botulinum product candidates and pipeline progress to my global industry colleagues,” commented Dr. Edelson.
IMCAS congresses are medical research conferences focused…